Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

European Journal of Immunology

Volumn 29, Issue 4, 1999, Pages 1390-1396

  Kodama, Tomohiro ^a,b   Takeda, Kazuyoshi ^a,c   Shimozato, Osamu ^a   Hayakawa, Yoshihiro ^d   Atsuta, Machiko ^a,c   Kobayashi, Kimio ^e   Ito, Mamoru ^e   Yagita, Hideo ^a,c   Okumura, Ko ^a,c  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

IL 12; NK cell; Perforin

Indexed keywords

FAS LIGAND; INTERLEUKIN 12; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; LIVER; LUNG METASTASIS; MALE; MELANOMA B16; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0032934504     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199904)29:04<1390::aid-immu1390>3.0.co;2-c     Document Type: Article

References (19)

1. Brunda, M. J., Interleukin-12. J. Leukoc. Biol. 1994. 55: 280-288.
2. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F. and Gately, M. K., Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 1993. 178: 1223-1230.
3. Nastala, C. L., Edington, H. D., Mckinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J. and Lotze, M. T., Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 1994. 153: 1697-1706.
4. + T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J. Immunol. 1996. 156: 3366-3373.
5. + αβ T cells in the lungs of euthymic and athymic mice. Immunology 1996 88: 82-89.
6. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M., Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
7. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 1998. 160:16-19.
8. Yu, W.-G., Yamamoto, N., Takenaka, H., Tai, J., Mu, X.-G., Zou, J.-P., Ogawa, M., Tsutsui, T., Wijesuriya, R., Yoshida, R., Herrmann, S., Fujiwara, H. and Hamaoka, T., Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rlL-12. Int. Immunol. 1996. 8: 855-865.
9. Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M. and Hamilton, T. A., The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 1998. 161: 927-932.
10. Laner, L. L., NK cell receptor. Anna. Rev. Immunol. 1998. 16: 359-393.
11. + T cells on experimental haematogenous tumor metastases in the liver and lungs of mice. Immunology 1997. 92: 561 -566.
12. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J. Immunol. 1998. 160: 3522-3527.
13. Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. and Hengartner, H., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994. 369: 31-37.
14. + thymocyte population associated with intact Fas antigen expression on the target. J. Exp. Med. 1994. 180: 423-432.
15. Arase, H., Arase, N. and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 1995. 181: 1235-1238.
16. van den Broek, M. F., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J. M., Zinkernagel, R. M. and Hengartner, H., Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 1996. 184: 1781-1790.
17. Davisodson, W. H., Giese, T. and Fredricson, T. N., Spontaneous Development of tumors in mice defective Fas-Fas ligand interaction. J. Exp. Med. 1998. 187: 1825-1838.
18. Gollob, J. A., Kawasaki, H. and Ritz, J., Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur. J. Immunol. 1997.27:647-652.
19. Sayers, T. J., Manson, A. T. and Ortaldo, J. R., Regulation of human natural killer cell activity by interferon-γ: lack of a role in interleukin 2-mediated augmentation. J.Immunol. 1986. 136: 2176-2180.